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PRECLINICAL RESEARCH
ccurate and Objective Infarct Sizing
y Contrast-Enhanced Magnetic Resonance
maging in a Canine Myocardial Infarction Model
uciano C. Amado, MD,* Bernhard L. Gerber, MD,* Sandeep N. Gupta, PHD,‡ Dan W. Rettmann, BS,‡
ilberto Szarf, MD,† Robert Schock, PHD,§ Khurram Nasir, MD, MPH,*
ara L. Kraitchman, VMD, PHD,† João A. C. Lima, MD*
altimore, Maryland; Waukesha, Wisconsin; and Mahwah, New Jersey
OBJECTIVES To identify an accurate and reproducible method to define myocardial infarct (MI) size, we
conducted a study in a closed-chest canine model of acute myocardial infarction, in which MI
size was measured using different thresholding techniques and by imaging at different delay
times after contrast administration.
BACKGROUND The MI size by contrast-enhanced magnetic resonance imaging (CE-MRI) is directly related
to long-term prognosis. However, previous measurements were done using nonuniform
methods and tended to overestimate nonviable areas.
METHODS Thirteen animals underwent 90 min of coronary artery occlusion, followed by reperfusion.
The CE-MRI data were acquired within 24 h after reperfusion and compared with
triphenyltetrazolium chloride pathology. In the first nine animals, images were obtained 15
min after gadolinium diethylene triamine penta-acetic acid (Gd-DTPA) using an inversion-
recovery gradient-echo pulse sequence. To identify the most accurate method, MI size by
CE-MRI was measured visually and by semi-automatic thresholding techniques, using
different criteria. In four additional animals, images were acquired every 6 min until 30 min
after Gd-DTPA.
RESULTS Postmortem MI size was 13.5 2.6% of left ventricular volume. Semi-automatic techniques,
using full-width at half-maximum (FWHM) criterion, correlated best with postmortem data
(r2  0.94, p  0.001; results confirmed by Bland-Altman plots). Using FWHM, there was
no difference in MI size between different delay times after contrast (15.2  2.9% to 14.5 
4.2% at 6 and 30 min, respectively; p  NS).
CONCLUSIONS When an objective technique is used to define MI size by CE-MRI, accurate infarct size
measurements can be obtained from images obtained up to 30 min after contrast
administration. (J Am Coll Cardiol 2004;44:2383–9) © 2004 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.09.020Cardiology Foundation
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the extent of injury after an ischemic event and the
istinction between viable and nonviable myocardium are
mportant for treatment decision-making. Contrast-
nhanced (CE) magnetic resonance imaging (MRI) is an
maging modality capable of high spatial resolution and able
o assess the presence of viable myocardium in infarcted and
oor contractile areas (1). In the chronic phase of myocar-
ial infarction (MI), delayed hyperenhancement has been
hown to correlate well with fibrosis and be a marker of
rreversible injury (2). Also, measurements of MI extent
etermined by CE-MRI have been demonstrated to predict
ong-term prognosis and play a key role in treatment (3,4).
From the Department of Medicine, Divisions of *Cardiology and †Radiology,
ohns Hopkins University, School of Medicine, Baltimore, Maryland; ‡GE Medical
ystems, Waukesha, Wisconsin; and §Datascope Corporation, Mahwah, New Jersey.
he National Institutes of Health (NIH, National Heart, Lung and Blood Institute
NHLBI] grants RO1-HL63439 and RO1-HL66075-01) and Datascope Corpora-
ion funded this research. Dr. Kraitchman is supported by grant K02-HL04193 from
he NHLBI. Drs. Kraitchman and Lima contributed equally to the concept and
esign of this study.m
Manuscript received February 16, 2004; revised manuscript received August 5,
004, accepted September 3, 2004.Various studies have shown that in the acute MI, CE
maging techniques tend to overestimate nonviable tissue
5–9). Many technical issues appear to be involved in this
rocess. Previous studies using CE-MRI have utilized
ifferent methods, different pulse sequences for imaging
cquisition, as well as different delays after contrast injec-
ion, making interpretation complex (1,5,6). Recently, a link
etween infarct overestimation and the delay time of imag-
ng acquisition after contrast injection has been proposed
9). However, other previous studies have produced data
uggesting that infarct size is reproducible between 10 and
0 min after contrast administration (10). The discrepancies
bserved between those studies could be attributed to
ethodologic differences and imply the need for an accurate
nd objective technique to define the extent of a delayed
yperenhanced region. Most studies have used arbitrary
riteria to define the extent of infarcted tissue from CE-
RI (5,9,11). Until now, no one has validated an ideal
echnique to define infarct size by CE-MRI.
This study represents an attempt to find a uniform
ethod to measure infarct size from delayed CE images.
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Accurate Infarct Size Measurement With CE-MRI December 21, 2004:2383–9or this purpose, we conducted a study with two main
bjectives: 1) to determine the most accurate and objec-
ive thresholding criterion to assess the presence and
xtent of viable myocardium in the acute phase of MI by
elayed CE-MRI images; and 2) to examine whether the
ize of a hyperenhanced area remains constant as a
unction of time.
ETHODS
xperimental protocol. All animal studies were approved
y our Institutional Animal Care and Use Committee and
omplied with the “Guidelines for the Care and Use of
aboratory Animals” (National Institutes of Health [NIH]
ublication no. 80-23, revised 1985). Thirteen mongrel
ogs (25 to 30 kg) were anesthetized, intubated, and
echanically ventilated. All animals received prophylaxis
ith antibiotics every 4 h.
xperimental MI. Catheter sheaths were placed in the
ight femoral artery (10-F) and right carotid artery (8-F).
fter this, the animals underwent heparinization (5,000 IU
ntravenously). A 6-F pigtail catheter was advanced through
he femoral artery into the left ventricular (LV) cavity for
entriculography and pressure monitoring. A coronary an-
ioplasty balloon (3.5-F, 20 mm) was advanced through the
ight carotid artery into the proximal left anterior descend-
ng coronary artery or left circumflex artery. Myocardial
nfarcts were created by inflating the angioplasty balloon for
0 min. After this period, the balloon was deflated and the
rtery reperfused.
he MRI protocol. To define the most accurate threshold
echnique to assess the extent of necrotic (nonviable) myo-
ardium, images were obtained at 24 h after MI in the first
ine animals. In the subsequent four animals, images were
cquired at 1 h after MI to examine the extent of the
yperenhanced region over time, after contrast injection.
ne hour was chosen as the time necessary to stabilize the
nimal after MI. All images were acquired using a 1.5-T
R scanner (CV/i, GE Medical Systems, Waukesha,
isconsin). Animals were placed in right decubitus with a
hased-array surface coil wrapped around the chest.
omparisons with infarct sizing methods. In the first
ine animals, images were acquired 15 min after a 0.2-
mol/kg intravenous injection of gadolinium diethylene
Abbreviations and Acronyms
CE  contrast-enhanced/enhancement
FWHM  full-width at half-maximum
Gd-DTPA  gadolinium diethylene triamine penta-
acetic acid
LV  left ventricle/ventricular
MI  myocardial infarct/infarction
MRI  magnetic resonance imaging
TI  inversion recovery time
TTC  triphenyltetrazolium chlorideriamine penta-acetic acid (Gd-DTPA) (Magnevist, Berlex daboratories, Montville, New Jersey), using an electrocar-
iographically gated, breath-hold, interleaved, inversion
ecovery, fast gradient echo pulse sequence: echo time of 3.3
s, repetition time of 7.3 ms, 8-mm slice thickness/no gap,
8 21-cm field of view, 256 196-160 image matrix, 25°
ip angle; two number of signals averaged, and 31.2-kHz
andwidth (12). The inversion recovery time (TI) was fixed
t 200 ms for the first image acquisition. Two observers
valuated the quality of the first delayed enhancement
mage, and adjustments to the TI were done if necessary to
chieve the best contrast between the normal and infarcted
yocardium. The overall measured TI was 223  9.2 ms.
iming delay study. The same protocol was used for the
ime delay study. However, for this protocol, imaging
cquisition was performed repeatedly starting immedi-
tely after contrast injection and continuing until 30 min
fter injection. Each set of images, covering the entire
eart from base to apex, was acquired in 6 min. A total
f five sets of images, each containing eight to nine
hort-axis images, were obtained from each animal (n 
). Small adjustments in TI were made to null the signal
ntensity from normal myocardium at different time
oints after contrast injection. The TI changed from
93.8  6.3% to 212.5  16.1% at 6 and 30 min after
ontrast injection, respectively (p  NS).
nalysis of MRI data. COMPARISON OF INFARCT SIZING
ETHOD STUDY. To determine the most accurate tech-
ique of measuring infarct size by CE-MRI, images were
ransferred to a SUN workstation (Sun Microsystems, Santa
lara, California) and analyzed using a custom research
oftware package (Cine Tool, GE Medical Systems). En-
ocardial and epicardial contours were traced manually.
nce the myocardial contours were identified, infarct areas
ere traced manually by two different observers using both
visual qualitative approach and objective semi-automatic
hresholding techniques. Various criteria based on the signal
ntensities of the normal and infarcted myocardium were
sed to semi-automatically threshold the infarct (Fig. 1).
-STANDARD DEVIATIONS ABOVE REMOTE. With this
echnique, the mean and standard deviation of the signal
ntensity from the remote (noninfarcted) myocardium re-
ion of interest was determined, and infarcted regions were
efined as areas presenting signal intensities above a certain
umber of standard deviations from the mean of the remote.
easurements were done using 1, 2, 3, 4, 5, and 6 standard
eviations above the remote mean (Fig. 1) (1,9).
ULL-WIDTH AT HALF-MAXIMUM (FWHM). Measurements
ere also done based on FWHM criterion (13,14). The user
licked in the hyperenhanced region to provide a seed point,
nd a multi-pass region-growing algorithm was used to
dentify the infarct boundaries by using the FWHM crite-
ion (Fig. 1).
ISUAL. Infarct size was also measured visually by two
ifferent observers, by manually defining the extent of
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December 21, 2004:2383–9 Accurate Infarct Size Measurement With CE-MRIyperenhanced area. Contouring was performed based on
ubjective visual identification of the infarct border.
iming delay study. The most accurate method of mea-
uring infarct size determined from the previous study was
hen employed to calculate MI size at different delay times
n four additional animals. All measurements of infarct size
ere expressed as a percentage of LV volume, given by the
um of the volume of the hyperenhanced regions for all
lices divided by the sum of the LV myocardial cross-
ectional volumes for all slices.
ostmortem measurements. After image acquisition, an-
mals were euthanized. The heart was excised and sectioned
nto 8-mm-thick short-axis slices and incubated in 2,3,5-
riphenyltetrazolium chloride (TTC) for 20 min at 38°C to
elineate viable myocardium (15). Each slice was photo-
raphed with a digital camera. Using a custom research
oftware package (Cine Tool, GE Medical Systems), TTC-
egative and LV borders were manually traced for each
lice. Infarct size was determined as the percentage of LV
olume.
tatistical analysis. Analysis was performed using STATA
oftware (Stata Corp., College Station, Texas). Infarct size
s expressed as the mean value  SEM. Pearson correlation
nd linear regression analysis were used to compare between
he different MRI measurements and MRI measurements
gainst postmortem measurements. Results were confirmed
ith repeated measurements analysis of variance and Bland-
ltman plots (16). The Bland-Altman repeatability analysis
ethod was used to compare semi-automatic and visual
echniques. A level of p  0.05 was considered statistically
igure 1. Delayed enhancement images and semi-automatic techniques
ull-width at half-maximum (FWHM) criterion—an initial region is dete
elected point. The maximum signal intensity (MX) inside this initial regio
ith a signal intensity 50% above the maximum of the initial region (MI 
ignal intensity (RI) under the yellow circle was determined. The extent of
rom the remote (MI  RI  SD). Measurements were done using 1, 2,ignificant. pESULTS
igure 2A shows excellent correspondence of the infarct size
easured by delayed CE-MRI images and TTC pathology.
he mean infarct size by TTC was 13.5  2.6% of the LV
olume.
omparison of infarct sizing method study. Table 1
ummarizes the results of MI size measured by different
hresholding techniques, compared with postmortem infarct
xtent. Compared with the postmortem data, the best
orrelation was achieved with MRI measurements based on
he FWHM thresholding technique (y  1.1x  2.3; r2 
.94) (Fig. 2A). Regression and Bland-Altman analysis
onfirmed the superiority of the FWHM technique (bias of
.1% of LV; p  0.001) (Fig. 2B), compared with the other
emi-automatic thresholding techniques tested (Fig. 3).
Figure 2C demonstrates the results of Bland-Altman
nalysis of interobserver reproducibility from semi-
utomatic and visual techniques. A much better reproduc-
bility was achieved with FWHM compared with visual
echniques (bias of 0.1% and 3.4% of LV for FWHM
nd visual measuring techniques, respectively).
iming delay study. Infarct size measurements from de-
ayed enhancement images acquired with different delay
imes were segmented using the FWHM criterion. There
as no significant difference in MI size (as percentage of LV
olume) between different delay times after contrast injec-
ion (from 15.2  2.9% to 14.5  4.2% at 6 and 30 min
fter contrast injection, respectively; p  NS).
Figure 4 depicts delay CE images at five different time
different criteria to quantify myocardial infarct (MI) extension: 1) the
d to grow to include all pixels with signal intensity (SI) 50% of a user
hen determined, and the final MI extent is defined as the area presenting
* 0.5). 2) n-standard deviation (SD) criteria—the mean  SD of remote
as defined as areas presenting with signal intensities above the mean value
5, and 6 SD above the mean value.using
rmine
n is t
MX
MI woints after contrast injection, from three different animals,
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Accurate Infarct Size Measurement With CE-MRI December 21, 2004:2383–9emonstrating excellent concordance of infarct size mea-
urements over time. Indeed, there was high agreement of
I size between the first set of images until 30 min after
ontrast injection (y  1x  0.8; r2  0.97, when measure-
ents obtained at 6 and 30 min were compared). Results
ere confirmed by Bland-Altman analysis (bias of0.2% of
V) (Fig. 5).
ISCUSSION
his study was designed to identify an accurate and objec-
ive method to measure infarct size from delayed CE-MRI
cans. Our results can be summarized as follows: 1) the
emi-automatic thresholding technique based on the
WHM criterion is an accurate and reproducible segmen-
ation method to define infarct size on delayed CE images;
) when using an accurate objective segmentation criterion,
he delay time of image acquisition after contrast injection is
ot an important factor in the accuracy of infarct size
easurements; and 3) using an accurate method to describe
igure 2. Infarct size measured by delayed contrast-enhanced magnetic reso
FWHM) and worst (6 SD) correlations against triphenyltetrazolium chlo
etween infarct size measured by the different criteria against TTC (FWH
nterobserver reproducibility studies obtained from visual and semi-autom
able 1. Statistical Analysis
FWHM 1 SD 2 SD
earson correlation (r2) 0.94 0.85 0.79
inear regression (p value) 0.001* 0.05* 0.05*
land-Altman plot (bias†) 4.1  1.1% 22.8  3.2% 11.8  2.5%Compared with postmortem data. †Bias expressed as percentage of left ventricle (mean 
FWHM  full-width at half-maximum; NS  not significant; SD  standard deviatioelayed hyperenhanced regions, no significant overestimation
f the infarct size is observed compared with postmortem.
E-MRI for myocardial viability. The extent of MI and
he ability to differentiate viable from nonviable tissue are
mportant variables for treatment decision-making. In car-
iology, measurements of infarct size by CE-MRI have
een validated as prognostic indicators after acute MI (3).
owever, there is ongoing debate regarding the potential
verestimation by the CE-MRI technique to assess local
iability and contractile functional recovery after an acute
vent or treatment intervention (2,5,8).
Although delayed contrast hyperenhancement has been
hown to accurately reflect myocellular necrosis, and
herefore to be a definite marker of absent myocardial
iability on ex vivo imaging, studies have reported an
verestimation of infarct size (7,17). More specifically,
ome studies have demonstrated improvement in circum-
erential shortening between one and seven weeks after
I in regions presenting with delayed hyperenhance-
imaging using different criteria. (A) The best full-width at half-maximum
TTC) pathology. (B) Bland-Altman analyses show the level of agreement
nd 1 SD for best and worst, respectively). (C) Bland-Altman analyses of
riteria methods.
3 SD 4 SD 5 SD 6 SD Visual
0.71 0.56 0.42 0.35 0.69
0.05* NS NS NS 0.05*
.0  2.1% 6.6  1.7% 8.1  1.8% 8.7  2.1% 8.6  1.9%nance
ride (6SD).
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December 21, 2004:2383–9 Accurate Infarct Size Measurement With CE-MRIent (5), and others have confirmed this inotropic
esponse in up to 41% of hyperenhanced segments (18),
uggesting viability. A potential explanation of these
ndings is the presence of a nontransmural infarction. In
his regard, Garot et al. (19) have shown that the
mprovement in contractile function in regions of hyper-
nhancement are related to the presence of nontransmu-
al infarction, suggesting a tethering to neighboring
iable regions. Additionally, Kim et al. (1) demonstrated
hat hyperenhanced regions tend to decrease in the range
f approximately three-fold from three days to eight
eeks after MI. This shrinkage effect can lead to erro-
eous interpretation in the differentiation of nontrans-
ural (defined as 50% of LV wall extension) from
ransmural (50% of LV wall) at the acute phase of MI.
hese data combined support the need for an accurate
igure 3. Comparison of infarct size measured from short-axis images by
echniques. The arrow demonstrates the border zone, areas with partial e
ssessing the delayed hyperenhanced area. The infarcted region was deline
ed: 1  visual; 2  standard deviation (1 SD); and 3  full-width at ha
oted, especially related to the inclusion of the border zone on the an
triphenyltetrazolium chloride [TTC] pathology).
igure 4. Differences in infarct size over time. This figure depicts delay
btained every 6 min after contrast injection until 30 min after contrast. T
ime points. There were high levels of agreement in measurement of myocardia
0 min after contrast injection.echnique to measure the extent of the necrotic area at
he acute phase of MI.
The reasons for infarct size overestimation by MRI are
ot completely understood. Partial volume effects intrin-
ic to slice thickness limitation are likely responsible for
ost of the infarct size overestimation. Potential mech-
nisms might also include the possibility that myocardial
dema without cell necrosis could produce late tissue
yperenhancement through an increase in the extracellu-
ar distribution of the contrast agent (20,21). In theory,
n interstitial water increase due to plasma infiltration
fter the hyperemic stage of acute MI could explain the
nfarct size overestimation observed in clinical and exper-
mental studies. However, the presence of extracellular
dema is difficult to document, and its magnitude is even
arder to quantify.
ed contrast-enhanced magnetic resonance imaging (MRI) using different
ement on the edge of the infarct, which may lead to visual ambiguity in
y the different techniques using different criteria, as shown by contours in
imum (FWHM). Significant variability among segmentation methods is
The MRI infarct size was compared with postmortem measurements
hancement short-axis images from three different animals. Images were
esence, location, and size of the hyperenhanced region were similar for alldelay
nhanc
ated b
lf-max
alysis.ed en
he prl infarct size between the first set of images at 6 min and all others up to
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Accurate Infarct Size Measurement With CE-MRI December 21, 2004:2383–9ccurate method for infarct sizing. Our study supports
he importance of choosing an accurate technique to mea-
ure infarct size by CE-MRI. As shown in Table 1,
mportant variations in MI size measurements were ob-
erved in our study when using different thresholds for
yocardial hyperenhancement (bias from 4.1  1.1% to
2.8  3.2% of LV for FWHM and 1 standard deviation
riteria, respectively).
Our results illustrate the ability of the FWHM criterion
o accurately measure infarct size by CE-MRI, compared
ith the other semi-automatic criteria. Most of the semi-
utomatic techniques previously published utilized the sig-
al intensity of areas outside the infarct to define hyperen-
anced regions. Surface coil intensity variations may
onfound the segmentation criteria when using a remote
egion to calculate the segmentation threshold. The
WHM criterion is based solely on the signal intensity
nside the infarcted area. Therefore, even in the case of
patial variations in intensity, the boundary determined by
his approach does not change, as it is relative to the local
nfarct signal maximum. Consequently, this approach
hould be less susceptible to surface coil intensity variations
Fig. 1).
Measurements using the semi-automatic FWHM tech-
ique demonstrate a reduction in interobserver variability
ompared with non-automatic visual techniques (bias of 3.4
nd 0.1% of LV for Bland-Altman repeatability analysis for
isual and FWHM techniques, respectively) (Fig. 4). These
esults reinforce the importance of using objective techniques
o reduce the possibility of human error.
Even when using the most accurate technique—
WHM—differences in infarct size measured by CE-MRI
nd at postmortem were still observed. This can be partly
xplained by differences between the two techniques: MRI
nfarct size measurements are based on the extension of the
ontrast (Gd-DTPA) penetration into the necrotic tissue,
hereas the TTC staining technique is related to the
xtension of tissue capable of reacting to the stain (TTC).
Also, problems with the TTC staining technique should
e considered. For example, potential limitations of slicing
he anatomic piece preceding the TTC staining are intrinsic
igure 5. Bland-Altman analysis demonstrates no important differences in
nfarct size measurements over time (bias of 0.2% of left ventricle).o this method; TTC staining requires a thermal- ionditioning step that can dehydrate the myocardium and
onsequently alter the infarct configuration, making it
ifficult to accurately delineate the infarct’s true dimensions.
inally, as a result of the thermal-conditioning step, myo-
ardial dehydration can lead to imprecise weighting of the
lices, as well as inaccuracies in infarct size measurements
ormalized by LV mass.
elayed time study. In our study, no significant differences
n MI extent were noted among CE-MRI measurements
erformed between 6 and 30 min after contrast injection.
hese results support the findings of Mahrholdt et al. (10),
ho reported that infarct size measured as the hyperen-
anced area on CE-MRI does not change between 10 and
0 min after contrast. Conversely, our findings diverge from
nother recent report by Oshinski et al. (9), who found a
ecrease from 60% of LV at 3 min to 30% of LV at 40 min
fter contrast injection.
The different results found in our study and the study by
shinski et al. (9) can be partly related to differences in
pecies, specific collateral flow, or edema formation second-
ry to different degrees of reperfusion injury (22). In
ddition, these discrepancies could be due to differences in
he MRI pulse sequences utilized in those studies (12). The
mportance of the TI (delay time between the inversion
ulse and data acquisition) to null the normal and nonin-
arcted myocardium has been emphasized in past studies
12). In our study, TI adjustments were performed for
dequate image acquisition (Fig. 4).
Furthermore, our study highlights a new and important
actor: the use of objective criteria to delineate the extension
f hyperenhanced myocardium defined by CE-MRI. As
hown by our findings, subjective measurements demon-
trated a variance as high as300% (from 6.0 2.1 to 22.8
3.2 for bias of 3 and 1 standard deviation techniques,
espectively) among different methods. These findings re-
nforce the importance of choosing an accurate technique to
easure infarct size in a clinical setting.
onclusions. This study documents the accuracy and re-
roducibility of the semi-automatic technique based on the
WHM criterion to measure infarct size by CE-MRI. In
ddition, the study demonstrates that by using an objective
egmentation technique, the delay time after contrast injec-
ion is not an important factor to the accuracy of infarct size
easurements by CE-MRI. Finally, our results suggest that
uture studies using CE-MRI to measure the extent of MI
hould consider the use of the FWHM criterion. These
ndings might have important implications to the interpre-
ation of CE-MRI methods to measure infarct size in a
linical setting.
cknowledgment
e thank Danielle Fritzges for her assistance in themplementation of the study.
R
A
5
M
R
1
1
1
1
1
1
1
1
1
1
2
2
2
2389JACC Vol. 44, No. 12, 2004 Amado et al.
December 21, 2004:2383–9 Accurate Infarct Size Measurement With CE-MRIeprint requests and correspondence: Dr. João A. C. Lima,
ssociate Professor of Medicine, Cardiology Division (Blalock
69), Johns Hopkins Hospital, 600 N. Wolfe Street, Baltimore,
aryland 2187-6568. E-mail: jlima@jhmi.edu.
EFERENCES
1. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed
contrast enhancement to irreversible injury, infarct age, and contractile
function. Circulation 1999;100:1992–2002.
2. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced
magnetic resonance imaging to identify reversible myocardial dysfunc-
tion. N Engl J Med 2000;343:1445–53.
3. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of
microvascular obstruction by magnetic resonance imaging in patients
with acute myocardial infarction. Circulation 1998;97:765–72.
4. Kramer CM, Rogers WJ, Theobald TM, et al. Remote noninfarcted
region dysfunction soon after first anterior myocardial infarction: a
magnetic resonance tagging study. Circulation 1996;94:660–6.
5. Rogers WJ Jr., Kramer CM, Geskin G, et al. Early contrast-enhanced
MRI predicts late functional recovery after reperfused myocardial
infarction. Circulation 1999;99:744–50.
6. Schaefer S, van Tyen R, Saloner D. Evaluation of myocardial perfu-
sion abnormalities with gadolinium-enhanced snapshot MR imaging
in humans. Work in progress. Radiology 1992;185:795–801.
7. Saeed M, Bremerich J, Wendland MF, et al. Reperfused myocardial
infarction as seen with use of necrosis-specific versus standard extra-
cellular MR contrast media in rats. Radiology 1999;213:247–57.
8. Kramer CM, McCreery CJ, Semonik L, et al. Global alterations in
mechanical function in healed reperfused first anterior myocardial
infarction. J Cardiovasc Magn Reson 2000;2:33–41.
9. Oshinski JN, Yang Z, Jones JR, et al. Imaging time after Gd-DTPA
injection is critical in using delayed enhancement to determine infarct
size accurately with magnetic resonance imaging. Circulation 2001;
104:2838–42.
0. Mahrholdt H, Wagner A, Holly TA, et al. Reproducibility of chronic
infarct size measurement by contrast-enhanced magnetic resonance
imaging. Circulation 2002;106:2322–7.1. Kim RJ, Judd RM, Chen EL, et al. Relationship of elevated 23Na
magnetic resonance image intensity to infarct size after acute reper-
fused myocardial infarction. Circulation 1999;100:185–92.
2. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging
technique for the visualization of myocardial infarction. Radiology
2001;218:215–23.
3. Hoffmann KR, Dmochowski J, Nazareth DP, et al. Vessel size
measurements in angiograms: manual measurements. Med Phys 2003;
30:681–8.
4. Hoffmann KR, Nazareth DP, Miskolczi L, et al. Vessel size measure-
ments in angiograms: a comparison of techniques. Med Phys 2002;
29:1622–33.
5. Rochitte CE, Lima JA, Bluemke DA, et al. Magnitude and time
course of microvascular obstruction and tissue injury after acute
myocardial infarction. Circulation 1998;98:1006–14.
6. Bland JM, Altman DG. Statistical methods for assessing agreement
between two methods of clinical measurement. Lancet 1986;1:307–
10.
7. Schaefer S, Malloy CR, Katz J, et al. Gadolinium-DTPA-enhanced
nuclear magnetic resonance imaging of reperfused myocardium:
identification of the myocardial bed at risk. J Am Coll Cardiol
1988;12:1064 –72.
8. Dendale P, Franken PR, Block P, et al. Contrast enhanced and
functional magnetic resonance imaging for the detection of viable
myocardium after infarction. Am Heart J 1998;135:875–80.
9. Garot J, Bluemke DA, Osman NF, et al. Transmural contractile
reserve after reperfused myocardial infarction in dogs. J Am Coll
Cardiol. 2000;36:2339–46.
0. Lima JA, Judd RM, Bazille A, et al. Regional heterogeneity of human
myocardial infarcts demonstrated by contrast-enhanced MRI: poten-
tial mechanisms. Circulation 1995;92:1117–25.
1. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of
myocardial contrast enhancement in fast magnetic resonance images of
2-day-old reperfused canine infarcts. Circulation 1995;92:1902–10.
2. Jennings RB, Schaper J, Hill ML, et al. Effect of reperfusion late in
the phase of reversible ischemic injury: changes in cell volume,
electrolytes, metabolites, and ultrastructure. Circ Res 1985;56:262–
78.
